Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Paclitaxel Albumin-Stabilized Nanoparticle Formulation, covering 2013-12-13 to 2023-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]